Applications and Prospects of Artificial Intelligence and Machine Learning in the Management of Cardiovascular and Cerebrovascular Diseases:An Interpretation of the American Heart Association's Scientific Statement on Improving Cardiovascular Outcomes Usin
Cardiovascular and cerebrovascular diseases are among the leading causes of death and disability worldwide.Despite continuous advancements in medical technology,the diagnosis and treatment of these diseases still face many unresolved challenges.The emergence of artificial intelligence and machine learning provides new approaches to addressing these issues.The American Heart Association's 2024 scientific statement highlights the applications and challenges of artificial intelligence and machine learning in clinical scenarios,including imaging analysis,electrocardiogram interpretation,bedside monitoring,wearable devices,genomics,and electronic health records.This paper aims to introduce these aspects and analyze the advantages of artificial intelligence and machine learning in the field of cerebrovascular diseases,providing a reference for the future development of artificial intelligence and machine learning in this area in China.